Skip to content
BY-NC-ND 3.0 license Open Access Published by De Gruyter Open Access May 30, 2010

Protective potential of L. acidophilus in murine giardiasis

  • Geeta Shukla EMAIL logo , Tarveen Kaur , Rakesh Sehgal , Praveen Rishi and Vijay Prabha
From the journal Open Medicine

Abstract

This study describes the in vivo activity of Lactobacillus acidophilus in Giardia lamblia infected BALB/c mice. Experimentally, it was observed that daily administration of lactobacilli 7 days before or in simultaneous inoculation with Giardia trophozoites efficiently reduced G. lamblia infection in mice. More specifically, excretion of Giardia cysts were reduced significantly in probiotic-treated groups, and resolution of infection was observed by day 21 post-inoculation. It was also observed that the lactobacillus count increased tremendously and continuously in faeces of all probiotic-fed mice, and was significantly higher as compared with that in control mice. Histological analysis of microvilli membrane integrity revealed that probiotic administration also protected mice against parasite-induced mucosal damage, whereas Giardia-infected mice had severe villous atrophy, oedema, vacuolation and ileitis. Immunologically, the anti-Giardia serum IgG level was not stimulated significantly by probiotic treatment administered both prior to and simultaneous with Giardia infection, but remained high after the infection peak. Taken together, the data demonstrates the anti-giardial effect of the probiotic in vivo by modulation of the intestinal epithelial cells, inhibiting the colonization of Giardia trophozoites and thereby reducing the severity of Giardia infection.

[1] Eckmann L., Mucosal defences against Giardia, Parasite Immunology, 2003, 25, 259–270 http://dx.doi.org/10.1046/j.1365-3024.2003.00634.x10.1046/j.1365-3024.2003.00634.xSearch in Google Scholar

[2] Upcroft P., Upcroft J. A., Drug targets and mechanisms and of resistance in the anaerobic protozoa, Clinical Microbiol. Rev., 2001,14, 150–164 http://dx.doi.org/10.1128/CMR.14.1.150-164.200110.1128/CMR.14.1.150-164.2001Search in Google Scholar

[3] Eckmanm L., Gillin F.D., Microbes and microbial toxis: paradigms for microbial-mucosal interactions. Pathophysiological aspects of enteric infections with the lumen dwelling protozoan Giardia lamblia, Am. J. Physio. Gestroenterology, 2001, 280, G1–G6 10.1152/ajpgi.2001.280.1.G1Search in Google Scholar

[4] Khanna R., Vinayak V.K., Mehta F.S., Kumkum R.K., Nain C.K., Giardia lamblia infection in immunosuppressed animals causes severe alterations to brush border membrane enzymes, Dig. Dis. Sci., 1998,33, 1147–1152 http://dx.doi.org/10.1007/BF0153579210.1007/BF01535792Search in Google Scholar

[5] Walia B.N., Ganguly N.K., Mahajan R.C., Kimar D., Madan I.J., Gambhir S.K., Kanwar S.S., Morbidity in pre school giardia cyst excretors, Trop. Geograp. Med., 1986, 38(4), 367–370 Search in Google Scholar

[6] Gardner T.B., Hill D.R., Treatment of Giardiasis, Clin. Microbiol. Rev., 2001,14: 114–128 http://dx.doi.org/10.1128/CMR.14.1.114-128.200110.1128/CMR.14.1.114-128.2001Search in Google Scholar

[7] Calzada F., Meckes M., Cedillo-Rivera R., Antiamoebic and antigiardial activity of plant flavonoids, Planta. Med., 1999, 65, 78–80 http://dx.doi.org/10.1055/s-2006-96044510.1055/s-2006-960445Search in Google Scholar

[8] Aggarwal A.K., Singh M., Gupta N., Management of giardiasis by an immuno-modulatory herbal drug Pippali rasayana, J. Ethropharmacol., 1994, 44,143–146 http://dx.doi.org/10.1016/0378-8741(94)01181-810.1016/0378-8741(94)01181-8Search in Google Scholar

[9] Kaneda Y., Torii M., Tanaka T., Aikawa M., In vitro effects of berberine sulphate on the growth and structure of Entamoeba histolytica, Giardia lamblia and Trichomonas vaginalis, Ann. Trop. Med. Parasitol., 1991, 85, 417–425 10.1080/00034983.1991.11812586Search in Google Scholar PubMed

[10] Oyetayo V.O., Adetuyi F.C., Akinyosoye F.A., Safety and protective effect of Lactobacillus acidophilus and Lactobacillus casei used as probiotic agent in vivo, Afr. J. Biotechnol. 2003, 2 (11), 448–452 10.5897/AJB2003.000-1090Search in Google Scholar

[11] Aattouri N., Bouras M., Tome D., Marcos A., Lemonnier D., Oral ingestion of lactic acid bacteria by rats increases lymphocyte proliferation and interferon — production, British. J., 2001, 87:367–373 10.1079/BJN2001527Search in Google Scholar

[12] Koop-Hoolihan L., Prophylactic and therapeutic uses of probiotics: A review, J. Am. Dietetic. Assoc., 2001, File: //G:/ Intern 1 10.1016/S0002-8223(01)00060-8Search in Google Scholar

[13] Diamond L.S., Technique of axenic culture of E. histolytica schaudinn, 1903 and E. histolytica like amoebae, J. Parasitol., 1963, 64, 1047–1056 10.2307/3277143Search in Google Scholar

[14] Benyacoub J., Perez P.F., Rochat F., Saudan K.Y., Reuteler G., Antille N., Humen M., De Antoni G.L., Cavadini C., Blum S., Schiffrin E.J., Enterococcus faecium SF68 enhances the immune response to Giardia intestinalis in mice, J. of Nutrition, 2005, 135, 1171–1176 10.1093/jn/135.5.1171Search in Google Scholar

[15] Tiwari R.P., Hoondal G.S., Tewari R., Laboratory Techniques in Microbiology and Biotechnology, 2001, Abhishek Publication Search in Google Scholar

[16] Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J., Protein measurement with folin’s phenol reagent, J. Bio. Chem. 1951, 193, 265–275 10.1016/S0021-9258(19)52451-6Search in Google Scholar

[17] Hudson L., Hay F.C., The lymphocyte: its role and function, Practical Immunology, 1980, Third edition, Blackwell Scientific Publication, Oxford, London Search in Google Scholar

[18] Oyetayo V.O., Oyetayo F.L., Potential of probiotics as biotherapeutic agents targeting the innate immune system, Afr J Biotechnol 2005, 4 (2), 123–127 Search in Google Scholar

[19] Singer S.M., Nash T.E., T-cell dependent control of acute Giardia lamblia infections in mice, Infect. Immunity, 2000, 68, 170–175 http://dx.doi.org/10.1128/IAI.68.1.170-175.200010.1128/IAI.68.1.170-175.2000Search in Google Scholar

[20] Humen M.A.L., De Antoni J., Benyacoud M.B., Costas M.I., Cardozo L., Kozubsky K., Saudan A., Doenzli-Bruand S., Blum E.J., Schiffrin P.F., Perez Lactobacillus johnsonii La1 antagonizes Giardia intestinalis in vivo, Infect. Immun., 2005, 73, 1265–1269 http://dx.doi.org/10.1128/IAI.73.2.1265-1269.200510.1128/IAI.73.2.1265-1269.2005Search in Google Scholar

[21] Perdigon G., Vintini E., Alvarez S., Medina M., Medici M., Study of the possible mechanisms involved in the mucosal immune system activation by lactic acid bacteria, J. Dairy Sci., 1999, 82, 1108–1114 http://dx.doi.org/10.3168/jds.S0022-0302(99)75333-610.3168/jds.S0022-0302(99)75333-6Search in Google Scholar

[22] Salminen S., Bouley C. Boutron-Ruault M.C., Functional food science and gastrointestinalphysiology and function, Br. J. Nutr., 1998, (suppl) s, 147–71 10.1079/BJN19980108Search in Google Scholar

[23] Isolauri E., Kalia M., Arvola T., Diet during rotavirus enteritis affects jejunal permeability to macromolecules in suckling rats, Pediatr. Res., 1993, 33, 548–53 http://dx.doi.org/10.1203/00006450-199306000-0000210.1203/00006450-199306000-00002Search in Google Scholar

[24] Farthing M.J.G., Diarrhoeal disease: current concepts and future challenges (pathogenesis of giardiasis), Trans. R. Soc. Trop. Med. Hyg., 1993, 87, S17–S21 http://dx.doi.org/10.1016/0035-9203(93)90531-T10.1016/0035-9203(93)90531-TSearch in Google Scholar

Published Online: 2010-5-30
Published in Print: 2010-8-1

© 2009 Versita Warsaw

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Downloaded on 26.4.2024 from https://www.degruyter.com/document/doi/10.2478/s11536-009-0139-x/html
Scroll to top button